Skip to main content

The PCB brings together research agents to discuss the innovation and development of science and technology parks

By 24 de November de 2004November 18th, 2020No Comments
< Back to news

The PCB brings together research agents to discuss the innovation and development of science and technology parks

On 25 November, the Ministry of Education and Science, the Spanish Association of Science and Technology Parks (APTE) and the PCB organised a conference on fostering Innovation and Development (I+D) in science and technology parks. Held in the PCB Auditorium, the conference, which brought together representatives from public administration and researchers from the public and private sectors, addressed the potential of these parks and also presented the PCB project.

The opening session, which began at 10h, was given by the Joan Bellavista, Commercial Director of the PCB and vice-president of the APTE, and Anicet Blanch, professor at the Universitat de Barcelona. The conference also included the participation of Ana Sánchez, head of Biotechnology and Food Technologies, part of the Directorate General for Technology Policy of the Ministry of Education and Science, who gave a speech on support measures for I+D in parks. In addition, Josep M. Vilalta, sub-director general of Research of the Dept. of Universities, Research and the Information Society, gave a presentation on research and innovation policies in Catalonia and projects that the Generalitat de Catalunya is financing in this field.

The PCB hosts research groups from the private and public sectors and provides them with a wide range of technological services. Joan Bellavista, and the director of the scientific division at the PCB, Montserrat Vendrell, also explained how the PCB model strengthens I+D.

Finally, the director of the Institute of Biomedical Research at the PCB (IRB-PCB), Joan J. Guinovart, the director of the Merck Pharma y Química Laboratory of Bioinvestigation, Jaume Piulats, the scientific director of the PCB Combinatorial Chemistry Platform, Fernando Albericio, and the director of Crystax Pharmaceuticals, Joan Aymamí, presented their experience as agents involved in research (public institute of research, consolidated company, technology platform and spin-off) that are located in a science park; a location which stimulates synergies between entities.